THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms of gambling, alcohol and tobacco.
On...
Akanda
Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not seen since October.
The NASDAQ-listed medical...
After 60-plus years of negativity and prohibition the tide has turned for hemp at the highest levels of global governance, explain Lorenza Romanese, Managing...
AT the end of 2022 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) held its first ‘technical expert meeting’ on hexahydrocannabinol, better...
Oxford Cannabinoid Technologies
THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the first significant growth in its...
FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.
On Tuesday, January 24, 2023, during a...
EARLIER this week, Czechia’s national anti-drug coordinator Jindřich Vobořil, described as the ‘locomotive’ driving rapid cannabis reform in the country, announced that draft legislation...
DELAYS in submitting its proposals to the European Commission and potential hold-ups once submitted could see Germany’s adult-use cannabis plans pushed back into 2025.
Originally...
LINNEA SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics license by Swissmedic at...
FOLLOWING the publication of a special report on industrial hemp, The United Nations Conference on Trade and Development (UNCTAD) is set to host a...
GOOGLE has made limited changes to its advertising policies to allow CBD topicals to be promoted on its platforms in three jurisdictions - California,...
Khiron Life Sciences
INTERNATIONAL medical cannabis company Khiron has seen its share price skyrocket over 60% following a crucial resolution that was passed by the...